Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$1.69 - $2.46 $11,492 - $16,728
-6,800 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$5.37 - $10.72 $8,055 - $16,080
-1,500 Reduced 18.07%
6,800 $38,000
Q4 2020

Jan 25, 2021

SELL
$3.08 - $7.79 $2,464 - $6,232
-800 Reduced 8.79%
8,300 $63,000
Q2 2020

Jul 27, 2020

BUY
$2.1 - $3.42 $17,430 - $28,386
8,300 Added 1037.5%
9,100 $27,000
Q4 2019

Jan 17, 2020

BUY
$2.82 - $12.9 $2,256 - $10,320
800 New
800 $4,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $36.5M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.